Pharmafile Logo
Pharmafocus logo
Advanced Search
kyprolis_amgen

Amgen’s Kyprolis doubles Velcade benefit in head-to-head study

December 5, 2015
Research and Development, Sales and Marketing Amgen, Cancer, Kyprolis, Takeda, Velcade, multiple myeloma

Amgen has announced that its multiple myeloma therapy Kyprolis displayed superiority to Takeda’s Velcade in the Phase III ENDEAVOR study …

News
l-r_alg_ceo_hugh_sheridan_with_cfo_jackie_fisher_and_coo_matt_guixe_-_low_res

ALG makes senior hires to increase global growth

December 4, 2015
Manufacturing and Production, Sales and Marketing

Medical products company ALG has hired Matt Guixe as chief operating officer and Jackie Fisher as chief financial officer. Guixe …

Appointment
Neusentis

Pfizer to close UK R&D site in surprise move

December 4, 2015
Research and Development, Sales and Marketing Pfizer

Two weeks after its $160 billion buyout of botox-maker Allergan, Pfizer has announced that it is to close a UK …

News
Logos

New regulatory submissions for AbbVie and Novo Nordisk

December 4, 2015
Medical Communications AbbVie, EMA, FDA, Novo Nordisk, Viekira Pak, insulin aspart

AbbVie and Novo Nordisk have submitted new drug applications to the US FDA and European Medicines Agency (EMA) respectively. The …

News
john_harris

OBN appoints Dr John Harris as chief executive

December 4, 2015
Medical Communications, Sales and Marketing OBN

OBN, the membership organisation supporting the UK’s emerging life sciences companies, has appointed Dr John Harris as its new chief executive, replacing …

Appointment
Teva image

Teva strips $1 billion worth of assets to clear Allergan deal

December 4, 2015
Medical Communications, Sales and Marketing Allergan, Teva, acquisitions, divestments, mergers

Teva Pharmaceuticals is thought to be in the process of stripping nearly $1 billion worth of assets to address antitrust …

News
Novartis image

NICE backtracks on Novartis Farydak decision

December 4, 2015
Medical Communications, Sales and Marketing Farydak, NICE, Novartis, panobinostat

NICE has reversed its earlier decision to reject the Novartis drug Farydak as an NHS treatment for people with multiple …

News
zometa

Cancer drugs prices vary up to 388% between high-income countries

December 4, 2015
Medical Communications, Sales and Marketing Cancer, Drug pricing, Eli Lilly, Genzyme, Lancet, Novartis, oncology

The price of new cancer drugs varies widely between high-income countries in Europe, Australia, and New Zealand, new research published …

News
digital

Big Pharma taking steps towards fully digital businesses

December 3, 2015
Medical Communications Accenture, digital pharma, innovation

Pharma companies can tap into $100 billion of revenue from being ‘digital transformers’, and not just ‘digital followers’, a leading …

News
alzheimers-oct-15-portraits-039

Chief scientific officers appointed at dementia Drug Discovery Alliance

December 3, 2015
Medical Communications, Research and Development Alzheimer's Research, dementia, dementia drug discovery alliance

Alzheimer’s Research UK has appointed three chief scientific officers to drive its £30million Drug Discovery Alliance. The Alliance, which unites …

Appointment
pic

Katja Stout joins Citigate Dewe Rogerson as director

December 3, 2015
Medical Communications Citigate Dewe Rogerson

Citigate Dewe Rogerson has appointed of Katja Stout (previously Toon) as a director in its life sciences team. Katja is …

Appointment
Alkermes' Richard Pops

Alkermes aims to take the next biotech step

December 3, 2015
Medical Communications, Research and Development Alkermes

“We think we can be the next Biogen, or a Celgene or a Vertex – we have that much firepower …

Feature

NICE turns down bone disorder drug for NHS

December 3, 2015
Research and Development Alexion, NICE, Strensiq

NICE has published draft guidance as part of its highly specialised technologies programme, not recommending Alexion Pharma’s Strensiq (asfotase alfa) …

News
Propeller Health smart inhaler

GSK collaborates on ‘smart inhaler’ technology for respiratory trials

December 3, 2015
Research and Development COPD, GSK, Propeller, Propeller Health, asthma, clinical trials, ellipta, inhalers, smart drugs, smart inhalers

GSK has entered the ‘smart drug’ industry by partnering with a health technology company to develop a sensor for use …

News
gsk_logo_with_text

GSK gets European approval for asthma treatment Nucala

December 3, 2015
Research and Development GSK, Nucala, asthma

GlaxoSmithKline has received marketing authorisation from the European Commission for Nucala as an add-on treatment for severe refractory eosinophilic asthma …

News
mbeya_microscopy

Janssen in new collaboration to take on TB

December 3, 2015
Research and Development FIND, Janssen, antibiotic resistance, tuberculosis

Janssen has announced a new collaboration with the non-profit organisation FIND to step-up the fight against the public health threat …

News
zafgen_logo

Second patient dies in Zafgen obesity trial

December 3, 2015
Research and Development

Zafgen has announced the death of a second participant in a Phase III clinical trial of its obesity drug beloranib …

News
Victoza

Novo Nordisk buys Xoma diabetes program and scores trial successes

December 2, 2015
Research and Development, Sales and Marketing Novo Nordisk, Ryzodeg, SGLT2 inhibitors, Victoza, Xoma, diabetes

Novo Nordisk has announced its purchase of a type 2 diabetes diabetes program in a deal with biotech firm Xoma …

News
EU flags

Horizon receives European go-ahead for Ravicti

December 2, 2015
Research and Development, Sales and Marketing Horizon Pharma, Ravicti, horizon, orphan drug, rare disease, urea cycle disorders

The European Commission has approved Ravicti for rare urea cycle disorders.  Ravicti, (glycerol phenylbutyrate), is an oral liquid developed by Horizon …

News

Personalised care key to diabetes management, says NICE

December 2, 2015
Research and Development NICE, NICE guidelines, diabetes, type 2 diabetes

UK drugs regulator NICE has published updated guidelines on type 2 diabetes, saying that taking an individualised approach to care …

News
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026